|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.500 MYR | 0.00% |
|
+0.35% | -2.86% |
Business description: IHH Healthcare
Number of employees: 76,000
Sales by Activity: IHH Healthcare
| Fiscal Period: December | 2021 (MYR) | 2022 (MYR) | 2023 (MYR) | 2024 (MYR) | 2025 (MYR) |
|---|---|---|---|---|---|
Hospital and Healthcare - Turkey and Europe | - | 438.97Cr | 564.3Cr | 724.9Cr | 845.8Cr |
Hospital and Healthcare - Singapore | 515.18Cr | 514.39Cr | 558.18Cr | 614.6Cr | 596.2Cr |
Hospital and Healthcare - Malaysia | 272.82Cr | 318.34Cr | 369.15Cr | 416.2Cr | 483.2Cr |
Hospital and Healthcare - India | 372.89Cr | 386.53Cr | 355.45Cr | 403Cr | 418.3Cr |
Hospital and Healthcare - Greater China | 88Cr | 100Cr | 130.68Cr | 153Cr | 162Cr |
Parkway Pantai - PPL Others | 251.45Cr | - | - | - | - |
Acibadem Holdings - Central and Eastern Europe(CEE) | 434.73Cr | - | - | - | - |
Labs | - | - | 166.8Cr | 177.9Cr | 173.9Cr |
Others | 139.69Cr | 154.4Cr | 149.83Cr | 111.3Cr | 135.8Cr |
Parkway Life Real Estate Investment Trust (Plife REIT) | 37Cr | 38Cr | 41Cr | 41Cr | 44Cr |
Unallocated MFRS129 | - | - | - | 12Cr | -48Cr |
Eliminations | -424.33Cr | -177.44Cr | -247.14Cr | -215.6Cr | -236.4Cr |
International Medical University (IMU) Health - Malaysia | 26Cr | 26Cr | 5.45Cr | - | - |
Geographical breakdown of sales: IHH Healthcare
| Fiscal Period: December | 2021 (MYR) | 2022 (MYR) | 2023 (MYR) | 2024 (MYR) | 2025 (MYR) |
|---|---|---|---|---|---|
Turkey and Europe | - | 438.49Cr | 567.36Cr | 742.3Cr | 809.1Cr |
Singapore | 503.33Cr | 514.31Cr | 574.56Cr | 630.4Cr | 610Cr |
Malaysia | 298.49Cr | 344.27Cr | 383.45Cr | 426.7Cr | 496Cr |
India | 372.88Cr | 386.53Cr | 421.58Cr | 470.7Cr | 482.7Cr |
Greater China | 88Cr | 100Cr | 130.68Cr | 152.8Cr | 162Cr |
Japan | 15Cr | 15Cr | 15Cr | 15Cr | 14Cr |
Other Regions | - | - | - | 70L | 80L |
Central Eastern Europe, Middle East and North Africa (CEEMENA) | 434.73Cr | - | - | - | - |
Unallocated | 76L | 49.94L | 56.59L | - | - |
Executive Committee: IHH Healthcare
| Manager | Title | Age | Since |
|---|---|---|---|
Prem Kumar Nair
CEO | Chief Executive Officer | 65 | 01/10/2023 |
Dilip Kadambi
DFI | Director of Finance/CFO | 51 | 01/05/2020 |
Hsiu Chin Lim
CTO | Chief Tech/Sci/R&D Officer | - | 29/09/2021 |
| Compliance Officer | 50 | 19/11/2018 | |
Kelvin Chong
IRC | Investor Relations Contact | - | 01/01/2021 |
Composition of the Board of Directors: IHH Healthcare
| Director | Title | Age | Since |
|---|---|---|---|
Mehmet Aydinlar
BRD | Director/Board Member | 68 | 24/01/2012 |
Satoshi Tanaka
BRD | Director/Board Member | 68 | 16/05/2011 |
Tomo Nagahiro
BRD | Director/Board Member | 50 | 01/02/2023 |
| Director/Board Member | 55 | - | |
Yoichiro Endo
BRD | Director/Board Member | 61 | 01/04/2024 |
Chua Bin Hwee
BRD | Director/Board Member | 69 | 14/08/2024 |
| Chairman | 66 | 26/06/2024 | |
Bin Hwee Quek
BRD | Director/Board Member | 69 | - |
| Director/Board Member | 49 | 17/09/2025 | |
Wah Yeow Tan
BRD | Director/Board Member | 65 | 17/09/2025 |
Holdings: IHH Healthcare
| Name | Stocks | % | Valuation |
|---|---|---|---|
FORTIS HEALTHCARE LIMITED 31.17% | 23,52,94,117 | 31.17% | 2 379 M $ |
| 21,49,58,644 | 32.93% | 673 M $ |
Company details: IHH Healthcare
Hospitals, Clinics & Primary Care Services
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | +0.35% | +29.38% | +45.80% | 1.83TCr | |
| +0.90% | +0.72% | +21.93% | +72.06% | 1.32TCr | |
| +2.88% | +8.24% | -28.62% | -53.90% | 1.19TCr | |
| +0.26% | +2.24% | +2.26% | +64.11% | 1.11TCr | |
| +0.44% | +2.17% | +25.76% | +85.49% | 992.73Cr | |
| -0.51% | 0.00% | -8.41% | -31.83% | 930.9Cr | |
| -0.13% | -1.74% | +19.12% | +189.07% | 746.68Cr | |
| +1.28% | +1.40% | +14.17% | -22.88% | 692.31Cr | |
| 0.00% | -2.19% | -26.40% | - | 674.57Cr | |
| -0.58% | +0.77% | +37.08% | +163.38% | 440.01Cr | |
| Average | +0.46% | +1.32% | +8.63% | +56.81% | 992.88Cr | |
| Weighted average by Cap. | +0.54% | +1.46% | +9.23% | +47.42% |
Sector
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 5225 Stock
- Company IHH Healthcare
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition